Information Provided By:
Fly News Breaks for January 22, 2020
BHC
Jan 22, 2020 | 06:36 EDT
Wells Fargo analyst Jacob Hughes upgraded Bausch Health Companies to Equal Weight from Underweight with a $32 price target. The analyst sees "solid" near-term organic growth for Bausch & Lomb and international organic growth. However, he sees this being offset by potential competitive threats to Xifaxan, mixed Sig7 sales trends, and Bausch's debt levels.